1905 Audubon Ct.
Spokane, WA 99224

08-10-2018 – TNTY – True Nature Executing on Growth Strategy With $6 Million Shelf Financing

ATLANTA, Aug. 10, 2018 (GLOBE NEWSWIRE) -- True Nature Holding, Inc. (OTCQB:TNTY) (the "Company" or "True Nature") today announced that it has executed a definitive term sheet and commitment for a shelf registration financing of up to $6 million dollars with GHS Investments, LLC (“GHS”), and that it is in discussions for bridge financing to fund its interim operating needs. Under terms of the agreement, the Company has the right at its sole discretion, but not the obligation, to sell up to $6 million of its common stock to GHS, in a tranche amounts as the Company determines.  In conjunction...

Read More

06-09-2018 – TPIV – TapImmune Announces Pricing of $70 Million Private Placement

Financing Led by New Enterprise Associates (NEA) Financing to Close Concurrently with Close of Merger with Marker Therapeutics JACKSONVILLE, Florida, June 8, 2018 – TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that it has entered into security purchase agreements with certain institutional and accredited investors in connection with a private placement of its equity securities.  The private placement will be led by New Enterprise Associates (NEA) with participation from Aisling Capital and Perceptive Advisors, among other new and existing investors.  The private placement is expected to be completed concurrently with the closing of the proposed merger between TapImmune Inc....

Read More